This standard was revised collaboratively by the American College of Radiology (ACR) and the Society of Nuclear Medicine (SNM). This standard was developed to cover key aspects pertinent to the performance of nuclear imaging and in-vivo nonimaging diagnostic studies using radio-pharmaceuticals.